Strontium-89 therapy for painful osseous metastatic prostate and breast cancer.

Article Details

Citation
Copy to clipboard

Hansen DV, Holmes ER, Catton G, Thorne DA, Chadwick DH, Schmutz DA

Strontium-89 therapy for painful osseous metastatic prostate and breast cancer.

Am Fam Physician. 1993 Jun;47(8):1795-800.

PubMed ID
7684554 [ View in PubMed
]
Abstract

Strontium-89 chloride is a radiopharmaceutical that localizes to actively forming new bone, such as metastatic bone lesions from prostate and breast cancer. It provides effective systemic endo-osseous local radiation therapy to these painful lesions. Strontium-89 will soon be available to physicians in the United States for use in the palliative management of metastatic bone pain.

DrugBank Data that Cites this Article

Drugs